Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Effectiveness of a Physical Activity Program (EPAP)

17 giugno 2026 aggiornato da: Federal University of Pará

Effectiveness of a Physical Activity Program in Adults and the Elderly

study with multicomponent exercise

Panoramica dello studio

Descrizione dettagliata

The objective of this research is to evaluate the effectiveness of a multicomponent physical activity program on the physical fitness of adults and the elderly. Participants will be adults and elderly individuals who perform physical activities in an extension project at the Federal University of Pará, Castanhal Campus, three times a week for 60 minutes. Each class will emphasize two physical capacities. Physical assessments will take place at the beginning and end of the school year and will include evaluations of the participants' profile, anthropometry, physical capacities, blood pressure, handgrip strength, and mental health. This research project aims to achieve the following goals: Conduct at least 80 assessments each year; Improve quality of life; Improve physical capacities; Reduce body circumferences; Improve muscle strength and handgrip strength; Encourage the participation of Physical Education students in research projects; Guide students in scientific work and in the preparation of their Final Course Projects; Participate in scientific events with presentations of work resulting from this research. Keywords: Adults; elderly people; physical activity; physical abilities.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

20

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Pará
      • Castanhal, Pará, Brasile, 68746-630
        • Universidade Federal do Pará

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

  • Adults
  • Older adults
  • Over 50 years of age of both sexes
  • Participating in an extension program at Federal University of Pará
  • Self-reported diagnosis of hypertension.

Exclusion Criteria:

  • Participants who did not agree with the study
  • Participants Who have low attendance in classes (below 50%).

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Intervention Group (IG)

The IG followed this protocol:

Week 1 - Day 1: thirty minutes of aerobic resistance exercises and 30 minutes of balance exercises; Day 2: 30 minutes of balance exercises.

Week 2 - Day 1: thirty minutes of strength exercises for upper and lower limbs and 30 minutes of balance exercises; Day 2: 30 minutes of balance exercises.

After week 2, the training returned to week 1 until completing ten weeks. The balance exercises used in the classes were static and dynamic, with 6 to 7 exercises and a duration of 30 to 45 minutes. In the first three weeks, the balance exercises were performed with two sets of 12 to 15 repetitions. From the fourth week onwards, there was a progression to three sets of 12 repetitions, and in the last four weeks, the exercises were performed with four sets of 12 repetitions.

Participants who were randomized to the intervention group performed 10 weeks of body balance exercise.
Participants who were randomized to the intervention or control group performed 10 weeks of multicomponent exercise.
Comparatore attivo: Control

Week 1 - Days 1 and 2: 30 minutes of aerobic endurance exercises and 30 minutes of flexibility exercises.

Week 2: Days 1 and 2: 30 minutes of strength training for upper and lower limbs and 30 minutes of balance exercises.

After week 2, the training returned to week 1 until completing the ten weeks.

Participants who were randomized to the intervention or control group performed 10 weeks of multicomponent exercise.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in lower limb muscle strength
Lasso di tempo: Baseline and after 10 weeks
The assessments included tests of lower limb strength (sit-to-stand test) - In this test, the participant must sit down and stand up from a chair. The total number of repetitions in 30 seconds is recorded.
Baseline and after 10 weeks
Change in upper limb strength
Lasso di tempo: Baseline and 10 weeks
Upper limb strength (forearm flexion test) - The forearm flexion test assesses upper body strength using two-kilogram dumbbells for women and four-kilogram dumbbells for men, a chair with a backrest (without armrests), and a stopwatch. The participant must be seated against the chair with an upright posture, performing the greatest number of bicep curls with their dominant hand in thirty seconds.
Baseline and 10 weeks
Change in lower limb flexibility
Lasso di tempo: Baseline and 10 weeks
Lower limb flexibility (sit-and-reach test) - With the leg extended (but not overextended), the participant slowly leans forward, keeping the spine as straight as possible and the head aligned with the spine. The participant attempts to touch their toes by sliding their hands, one on top of the other, with the tips of their middle fingers, down the extended leg. The evaluator uses a 45 cm ruler and records the distance (cm) to the toes (minimum result) or the distance (cm) that can be reached beyond the toes (maximum result).
Baseline and 10 weeks
Change in body balance
Lasso di tempo: Baseline and 10 weeks
agility/dynamic balance (sit-to-walk 2.44m and return to sit test) - The person being evaluated starts in a seated position in a chair with an upright posture, hands on thighs and feet on the floor with one foot slightly in front of the other. At the signal, the person being evaluated gets up from the chair (they can push off with their thighs or the chair), walks as quickly as possible around the cone, returns to the chair and sits down. For reliable timing, the evaluator should start the stopwatch at the signal movement, whether or not the person has started moving, and stop the stopwatch the exact moment the person sits down in the chair.
Baseline and 10 weeks
Change in upper limb flexibility
Lasso di tempo: Baseline and 10 weeks
Upper limb flexibility (behind-the-back reach test) - Standing, the subject places their preferred hand on the same shoulder, palm open and fingers extended, reaching as far as possible to the middle of their back (elbow pointing upwards). The hand of the other arm is placed behind the back, palm upwards, reaching upwards as far as possible in an attempt to touch or overlap the extended middle fingers of both hands. Without moving the subject's hands, the evaluator helps to verify if the middle fingers of each hand are pointing towards each other. The overlap distance, or the distance between the tips of the middle fingers, is measured to the nearest centimeter. Negative results (-) represent the shortest distance between the middle fingers; positive results (+) represent the overlap of the middle fingers.
Baseline and 10 weeks
Change in aerobic endurance
Lasso di tempo: Baseline and 10 weeks
Aerobic endurance (6-minute walk) - At the indicated signal, participants walk as fast as possible (without running) around the course as many times as they can within the time limit. During the test, participants may stop and rest if necessary, and then resume walking. The evaluator must move onto the course after all participants have started and must record the elapsed time. The 6-minute walk test uses a 45.7 m course measured in 4.57 m segments. The distance covered in the 6-minute interval will be assessed.
Baseline and 10 weeks

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in body mass
Lasso di tempo: Baseline and 10 weeks
Body mass (BM) - measurement obtained in kilograms using a digital scale.
Baseline and 10 weeks
Height Assessment
Lasso di tempo: Baseline and 10 weeks
Height (meters) - will be obtained using a stadiometer.
Baseline and 10 weeks
Change in waist circumference
Lasso di tempo: Baseline and 10 weeks
waist circumference (WC) - measurement obtained in centimeters using a measuring tape
Baseline and 10 weeks
Change in hip circumference
Lasso di tempo: Baseline and 10 weeks
Hip circumference (HC) - a measurement obtained in centimeters using a measuring tape.
Baseline and 10 weeks
Change in Body Mass Index (BMI)
Lasso di tempo: Baseline and 10 weeks
Body Mass Index (BMI) - will be assessed by dividing body mass in kilograms by height squared in meters.
Baseline and 10 weeks
Change in Percentage of fat
Lasso di tempo: Baseline and 10 weeks
Percentage of fat (%BF) - a measurement obtained as a percentage using a bioimpedance scale.
Baseline and 10 weeks
Change in percentage of skeletal muscle
Lasso di tempo: Baseline and 10 weeks
Percentage of skeletal muscle (%SM) - a measurement obtained as a percentage using a bioimpedance scale.
Baseline and 10 weeks

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

25 agosto 2025

Completamento primario (Effettivo)

18 settembre 2025

Completamento dello studio (Effettivo)

2 dicembre 2025

Date di iscrizione allo studio

Primo inviato

29 maggio 2026

Primo inviato che soddisfa i criteri di controllo qualità

17 giugno 2026

Primo Inserito (Effettivo)

23 giugno 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

23 giugno 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

17 giugno 2026

Ultimo verificato

1 giugno 2026

Maggiori informazioni

Termini relativi a questo studio

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • EPAP

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi